Interní Med. 2018; 20(3): 139-142 | DOI: 10.36290/int.2018.025

Anaphylaxis – diagnosis and management

doc. MUDr. Petr Kučera, Ph.D., MUDr. Iva Strnadová
Ústav imunologie, Oddělení alergologie a klinické imunologie, 3. lékařská fakulta Univerzity Karlovy
a Fakultní nemocnice Královské Vinohrady Praha

Anaphylaxis is a clinical emergency, all healtcare professinals should be familiar with its diagnosis and acute and ongoing management.Here, we present updated recommendations for recognition, risk factor assesment and patiens management.

Keywords: anaphylaxis, mast cells, IgE, epinephrin, autoinjector, allergen immunotherapy

Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kučera P, Strnadová I. Anaphylaxis – diagnosis and management. Interní Med. 2018;20(3):139-142. doi: 10.36290/int.2018.025.
Download citation

References

  1. Panesar SS, Javad S, Da silva D, et al. The epidemiology of Anaphylaxis in Europe: a systematic review. Allergy, 2013; 68: 1353-1361. Go to original source... Go to PubMed...
  2. Muraro A, et al. Anaphylaxis: guideline from the European Academy of Allergy and CLinical Immunology. Allergy, 2014; 69: 1026-1045. Go to original source... Go to PubMed...
  3. Sampson HH, Munozu-Furlon A, Cambel R, et al., summary report.et al. Second symposium on the definition and management of anaphylaxis. J Allergy Clin Immunol, 2006; 117: 391-397. Go to original source... Go to PubMed...
  4. Ring J, Mesmer K, Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1997; 309: 466-469. Go to original source... Go to PubMed...
  5. Mueller HL, Diagnostic and treatment of insects sensitivity, J Asthma Res, 1966; 3: 331-333. Go to original source... Go to PubMed...
  6. Niggemann B, Beyer K. Time for a new grading system for allergic reaction? Allergy 2016; 71: 135-136. Go to original source... Go to PubMed...
  7. Nováková L, Kučera P, Systémová mastocytóza. Transfuze Hematol dnes, 2009; 15: 31-38.
  8. Matito A, Alvarez-wose I, Morgado JM, et al. Anaphylaxis as a clinical manifestation of clonal mast cell disorders. Curr Allergy Asthma Rep, 2014; 14(450): 1-10. Go to original source... Go to PubMed...
  9. Turner PJ, Jerschow E, Umasunthar T, Lin R, et al. Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract. 2017; 5(5): 1169-1178. Go to original source... Go to PubMed...
  10. Akuete K, Guffey D, Israelsen RB, Broyles JM, et al. Multicenter prevalence of anaphylaxis in clinic-based oral food challenges. Ann Allergy Asthma Immunol 2017; 119: 339-348. Go to original source... Go to PubMed...
  11. Bělohlávková S, Kopelentová E, Šetinová I, et al. Registr potravinových alergií DAFALL - první výsledky. Alergie 2015; 2: 80-89.
  12. Billo MB, Bonifazi F, The natural history and epidemiology of insect venom allergy: clinical implications. Clin Experiment Allergy, 2009; 39: 1467-1476. Go to original source... Go to PubMed...
  13. Pesek RD, Management of Insect Sting Hypersensitivity: An Update. Allergy Asthma Immunol Res, 2013; 5: 129-137. Go to original source... Go to PubMed...
  14. Clark S, Long AA, Gaeta TJ, Camargo "CA. Multicenter study of emergency department visits for insect sing allergies. J Allergy Clin Immunool, 2005; 116: 643-649. Go to original source... Go to PubMed...
  15. Fleming JT, Clark S, Camargo CA Jr, et al. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015; 3: 57-62. Go to original source... Go to PubMed...
  16. Petrů V. Chyby a omyly v diagnostice a léčbě anafylaxe. Postgrad Med 2017; 19(3): 285-290.
  17. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from European Academy of Allergy and Clinical Immunology. Allergy 2014; 69: 1026-1045. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.